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Background: Turner’s syndrome (TS) is depicted as a total or partial absence of one X chromosome that results in
ovarian dysgenesis. Chances of spontaneous pregnancy in TS are rare and the outcome of the pregnancies is
known to be poor with an increased risk of miscarriage and stillbirths. Our aim is to evaluate reproductive and
obstetric outcomes of natural conception and in-vitro fertilization (IVF) cycles in mosaic TS patients.
Methods: A total of 22 mosaic TS cases (seventeen 45,X/46,XX and five 45,X/46,XX/47,XXX karyotypes) were evaluated.
Results: Live birth and abortion rates were found as 32.7 % and 67.3 %, respectively in 52 pregnancies. Implantation,
clinical pregnancy and take home baby rates were detected as 3.7 %, 8.6 % and 5.7 %, respectively per IVF cycle as a
result of 35 cycles. Fecundability analysis revealed that 5 % of the cases experienced first pregnancy within 6 months
and 8 % within the first 2 years. Mosaicism ratio did not have an effect on the time to the first pregnancy (p = .149).
Conclusion: Only a small proportion of the mosaic TS patients conceive in the first 2 years of the marriage. Age of
menarche and age of marriage appear not to have any impact on the chance of conceiving. Mosaic TS cases should
counseled about the low odds of pregnancy and high miscarriage rates.
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Turner’s syndrome (TS) is depicted as a total or partial
absence of one X chromosome, and occurs in approxi-
mately 1/2200 of live born females [1]. Nearly 43-49 %
of the patients are cases with classical TS who are
monosomic for X chromosome (45,X). The remaining
patients are mosaic cases carrying normal and abnormal
cell lines together (most of them had 45,X/46,XX karyo-
type) (15-23 %), those with isochromosome in long arm
of X chromosome (i(Xq)) (14 %), those with ring X
chromosome (r(X)) (3-11 %) and those with 46,XX
karyotype but having partial losses in one X chromo-
some (9 %). Y chromosome fragments are detected in
10-11 % of the cases [2–6].
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and besides, gonadal dysgenesis in TS results in pubertal
delay or failure, infertility and premature ovarian failure
(POF) in most patients [7, 8]. Although correlation be-
tween genotype and phenotype is not well understood,
mosaic cases present milder phenotypic abnormalities
compared to those with 45,X karyotype [9]. Mosaic TS
patients are more likely to experience normal pubertal
development, regular menstrual cycles and to conceive
spontaneously compared to those with 45,X monosomy
[2]. Since mosaic patients are diagnosed following karyo-
type analysis due to recurrent pregnancy loss, repeated
in vitro fertilization (IVF) failure and history of an abnor-
mal offspring, our knowledge concerning reproductive
and obstetric outcomes relies on case reports and case
series [4, 10–12] and more comprehensive studies investi-
gating the fertility outcomes of these patients.
The purpose of this study was to evaluate reproductive
and obstetric outcomes of natural conception and IVF
procedures in mosaic TS cases.ticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Table 1 Clinical characteristics of the study group
Patients age at the time of enrollment (years)a 37 (26–47)
Patients age at the time of diagnosis (years)a 34.5 (18–46)
Age of menarche (years)a 13 (11–18)
Age at marriage (years)a 25 (15–40)
Patients age at first pregnancy (years)a,b 23 (18–32)
Time from the marriage to the first conception
(months)a,b
12 (6–49)
Height of the patients (cm)a 163 (132–174)
Body mass index at the enrollment (kg/m2)c 28.43 ± 1.21
aData presented as median and range, bIn the cases who conceived
spontaneously, c data presented as mean ± standart error
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This retrospective study evaluated 706 female patients
who underwent karyotyping between 2009–2013 in the
laboratory of Medical Genetics Department of our
tertiary health institution. The approval from the local
ethics committee had been obtained prior to the initi-
ation of the study. Informed consent from all individual
participants included was obtained. Chromosomal analysis
was performed by G-banding technique at high resolution.
A hundred metaphases were counted for each patient and
International System for Human Cytogenetic Nomenclature
(ISCN, 2009) guidelines were used when performing karyo-
type analysis [13].
Mosaicism ratios of the cases were calculated by propor-
tioning total number of abnormal cell lines. In karyotype
analysis, mosaic cell line ratio of ≤%10 was defined as low-
grade mosaicism, and >%10 as high-grade mosaicism [14].
Medical history regarding prior hormone therapy,
prior assisted reproductive techniques attempts in infer-
tility cases, obstetric outcomes in patients who had con-
ceived through spontaneous or IVF cycles and perinatal
outcomes were obtained by face-to-face interview or
assessment of hospital medical records. All patients were
assessed with physical examination and underwent a set
of diagnostic tests including thyroid function tests,
abdominal ultrasonography and echocardiography.
Statistical analysis
SPSS version 15.0 (Statistical Package for Social Science,
Spss Inc. Chicago, IL, USA) was used for statistical ana-
lysis. Parametric variables were given as median (range),
mean ± standard deviation or ± standard error. Chi-square
test was used for the comparison of parametric variables.
Non-parametric tests such as Mann–Whitney U test was
used to compare non-parametric variables between cases
with high-grade mosaicisim and low-grade mosaicism.
Possibility of a total of 2-year fecundability was calculated
at 6-month intervals by time-table analysis. The effect of
menarche age, marriage age and mosaicism ratio on the
time until spontaneous or IVF pregnancy was assessed by
Cox-regression analysis. p < 0.05 was considered as statis-
tically significant.
Results
A total of 22 mosaic TS patients were extracted from
706 patients who underwent genetic karyotyping for
varying indications including, recurrent implantation
failure (5.1 %), recurrent pregnancy loss (defined as three
or more consecutive miscarriage) (2.2 %), POF (2.2 %)
and history of an offspring with any chromosomal or
structural abnormality (4 %). Clinical characteristics of
our study population were presented in Table 1. Menar-
che was achieved with hormone replacement therapy in
three cases at the ages of 16,17 and 18 years andcontinued regularly. Menstruation was regular in 18
cases at the time of study enrollment whereas it was
irregular in the two and the remaining two, who were
diagnosed as POF at the ages of 28 and 38, were on hor-
mone replacement therapy. There was one case with a
short stature (<150 cm) phenotype and no cases with
cardiovascular or renal abnormality, hearing loss and
mental retardation among the included patients. The
following systemic disorders were diagnosed in the
patients; hypothyroidism in three, type 2 diabetes in
three, asthma in one and generalized anxiety disorder in
one patients. Uterine hypoplasia was observed in one
case. In addition, one patient underwent hysteroscopic
septum resection for uterine septum, another case
underwent Strasmann metroplasty for bicornuat uterus
and one underwent hysteroscopy and cavity expansion
with fundal and lateral incisions for T-shaped uterus.
A total of 22 female patients, who were diagnosed as
mosaic TS after karyotyping and who attended our IVF
clinic with the diagnoses of recurrent implantation fail-
ure (n = 10), recurrent pregnancy loss (n = 9), infertility
due to POF (n = 1), and history of a prior offspring with
a chromosomal abnormality (n = 2), were included in
the study. Out of 22 patients, five despite IVF treatment
and one who never sought treatment, could not ever
conceive. Out of remaining 16 cases, 11 conceived spon-
taneously and five conceived following IVF cycles;
resulting in a total of 52 pregnancies of which 17
(32.7 %) resulted in live birth and 35 (67.3 %) resulted in
abortion.
Of 22 mosaic TS patients’ karyotypes, 17 were 45,X/
46,XX and five were 45,X/46,XX/47,XXX. There were
no cases including 45,X/46,Xr(X); 45,X/46,X(i(Xq)); Y
chromosome fragment or 46,XX karyotype with struc-
tural abnormalities in X chromosome. One patient was
determined to have 45,X/46,XX inv(9)p11q13 karyotype.
The comparison regarding the number and the percent-
ages of pregnancies, miscarriages and live births between
the different karyotypes of TS were presented in Table 2.
Table 2 Comparison of the ratios of live birth and miscarriage








No of pregnancies (n) 35 17 52 .678
Live birth (n (%)) 10 (28.6) 7 (41.2) 17 (32.7) .611
Miscarriage (n (%)) 25 (71.4) 10 (58.8) 35 (67.3) .712
p < .05 Statistically significant
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10 % in five cases. The comparison regarding the number
and the percentages of pregnancies, miscarriages and live
births between high-grade and low-grade mosaicism cases
were presented in Table 3. Miscarriages included 29 spon-
taneous abortions, four biochemical abortions and two in-
duced abortions (due to anencephaly and trisomy 21).
Mean abortion week was found to be 8.16 ± 2.98 (±SD) in
cases who experienced spontaneous abortion (Biochemical
abortions were excluded from the calculation).
A total of 82 embryo transfers were performed on 10
patients during 35 intracytoplasmic sperm injection
(ICSI) treatment cycles. Five patients could not conceive
despite ICSI and five cases could conceive following ICSI
treatment. Out of these pregnancies, one clinical preg-
nancy resulted in spontaneous abortion, two pregnancies
resulted in biochemical abortion and two live babies
were taken home. Implantation rate per cycle was 3.7 %
(3/82), clinical pregnancy rate was 8.6 % (3/35) and take
home baby rate was 5.7 % (2/35). 90.4 % of the pregnan-
cies (n = 47) (88.2 % of live born babies (n = 15)) have
occurred in spontaneous cycles.
Perinatal outcomes of the 17 pregnancies that resulted
in live birth are presented in Table 4. Mean birth weight
of these newborns was found as 3355 ± 140 gr (±SE).
Prenatal or postnatal cytogenetic examination was
performed in three pregnancies, two as prenatal and one
as postnatal investigations. Out of two prenatal cytogen-
etic examinations, one patient was diagnosed as Trisomy
21 and subsequently underwent a pregnancy termin-
ation; whereas the other revealed a normal karyotype.
The postnatal investigation was of a patient who under-
went karyotype analysis at the age of 15 due to mental
retardation and a deletion was detected between the re-
gions of 18q21.3 and q23. None of the miscarriages were
evaluated genetically from the abortus materials.Table 3 Comparison of the ratios of live birth and miscarriage or term
Mosaic cell line ratio Cases with low grade
mosaic cell line (n = 17)
C
m
No of Pregnancies (n) 46 6
Miscarriage (n (%)) 30 (65.2) 5
Live Birth (n (%)) 16 (34.8) 1
p < .05 Statistically significantTime table analysis revealed that pregnancy hazard
rate within the first 2 years at 6-month intervals was
found to be 0.01 in the first 6 months, 0.04 in the sec-
ond 6 months, 0.02 in the third 6 months and 0.01 in
the last 6 months. Neither spontaneous nor IVF preg-
nancy was detected beyond 60th month of marriage.
COX regression analysis revealed that marriage age, me-
narche age and mosaicism ratio did not have an effect
on the time until first pregnancy (p = .685; p = .350 and
p = .149, respectively).
Discussion
Gonadal dysgenesis in women with Turner Syndrome
might depend on chromosome pairing failure during
meiotic prophase, causing failure in synaptic formation
at the zygotene and oocyte loss [15]. Majority of germ
cells, which trigger spontaneous puberty in 10-30 % and
provide pubertal development, start to diminish in the
third month of intrauterine life, resulting in only 5-10 %
of affected patients could menstruate regularly [16–19].
POF is another frequent clinical feature of TS and mean
age of menopause was reported to be 29.3 years [18].
However; the degree of gonadal dysgenesis depends on
the size of impaired regions of homologous chromo-
somes. Severe pairing failures induce the degeneration of
all oocytes prior to puberty and are associated with
rimary amenorrhea and poor sexual development,
whereas mild pairing failures contribute to the survival
of a considerable number of oocytes until puberty, lead-
ing to secondary amenorrhea and secondary impaired
sexual development [15]. Thus, it is possible that
puberty and reproductive capacities are less affected or
even preserved in TS cases with mosaic karyotype [19].
When compared to the classical form, mosaic karyotype
TS cases are more likely to present spontaneous puberty,
normal levels of serum sex steroids and gonadotropins
and follicles in ovarian biopsies [20]. In addition, the
chance of spontaneous conceiving in women with TS
was reported as 2-10 %, most of which are the cases of
mosaic pattern and those with 45,X monosomy are
candidates for oocyte donation [16, 21, 22].
X chromosome monosomy and mosaicism are en-
countered in 1.5 % of all amenorrhea cases although the
incidence of X chromosome mosaicism in the general
population still remains challenging [23]. In our study,
we detected mosaic Turner karyotype in 2.2 % of theinated fetus between low and high grade mosaic cell line groups
ases with high grade
osaic cell line (n = 5)
All cases (n = 22) p
52 .062
(83.3) 35 (67.3) .468
(16.7) 17 (32.7) .127




Vaginal 9 52.9 %
Abdominal (C/S) 8 47.1 %
Fetal gender
Female 12 70.6 %
Male 5 29.4 %
Adverse perinatal outcomes
IUGR 1 5.9 %
P.previa 1 5.9 %
GDM 2 11.8 %
C/S, cesarean section; IUGR, intrauterine growth restriction; P.previa, placenta
previa; GDM, gestational diabetes mellitus
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5.1 % of the cases with recurrent implantation failure.
Our study results are compatible with the previously
published reports which indicated the rate of mosaic
Turner karyotype in the recurrent pregnancy loss groups
as 2.6 % [24]. X chromosome mosaicism ratio in female
partner of ICSI candidate couples was reported to be
2.77-4.12 % whereas 45X/46XX mosaicism in couples
with IVF failures due to severe male infertility and
fertilization failures were reported to be 3.5-9.6 %
[25–28]. Simpson et al. suggested that mosaicism has
been underestimated as a cause of repeated failure in
assisted reproduction [29].
The median age of marriage was 25 (15–40) and me-
dian age of first pregnancy in spontaneously pregnant
women was 23 years (18–32) and these results are in
agreement with the previous studies reporting median
age of first pregnancy in TS syndrome cases as 23.5-
27.2 years [4, 10]. ROC analysis revealed that marriage
age had no impact on the chance of conceiving. More-
over, Cox-regression analysis demonstrated that the age
of menarche, age of marriage and mosaicism ratio did
not affect the time-to-first pregnancy. There were no
significant difference between high-grade and low-grade
mosaicism cases in terms of pregnancy, time-to-first
spontaneous pregnancy, abortion and take home baby
rates in our study. Several previously published reports
indicated a correlation between mosaicism ratio and
phenotypic abnormalities and reproductive capacity of
the patients; on the contrary, some other publications
did not find a consistent relationship [2, 30]. Scholtes
et al. showed a correlation between mosaicism and a low
implantation rate [31]. In contrast, Sonntag et al. could
not find any significant impact of low-grade mosaicism
on the course or outcome of ICSI in 20 couples [14]. No
required minimum percentage of abnormal cells has
been established to define true versus “low-grade”mosaicism. Thus, some studies disregard the importance
of low-grade mosaicism [26]. In our study, first two-year
fecundability analyses revealed that 5 % of the cases ex-
perienced their first pregnancy within 6 months and 8 %
within first 2 years. No pregnancy was detected after
60 months of marriage. With the expectation of reduc-
tion in ovarian reserve with advanced age in TS, our
results revealed that chance of fertility in cases with mo-
saic karyotype was high at younger ages but their chance
will decrease if they do not conveive within the first 2 years.
Majority of TS cases who conceive spontaneously are
known to have mosaic cell lines. In the study by Birkebaek
et al., evaluating 410 Danish women with TS, 27 out of 31
women who could spontaneously conceive, at least once,
had a TS diagnosis [4]. Similarly in the study by Bryman
et al. there were 45,X/46,XX mosaicism in 25 out of 27
Swedish women with TS. While 23 cases had a spontan-
eous pregnancy, three cases conceived by assisted repro-
ductive technologies [32]. Clinical pregnancy rate and
implantation rate were reported to be 46 % and 30 %,
respectively, by fresh embryo transfer in oocyte donation
cycles, and 28 % and 19 %, respectively, in frozen embryo
transfers in TS cases [33]. Pregnancy rates of these cases
were found to be comparable with other women in
donation programs or probably lower due to diminished
endometrial receptivity [34, 35].
Many studies have shown that TS women who are able
to conceive are at increased risk for miscarriage, stillbirths
and malformed babies [7, 10, 36, 37]. Tarani et al. analyzed
160 spontaneous pregnancies in 74 women with TS and
reported that 67.3 % of the pregnancies with 45,X/46,XX
karyotype and 70.8 % of the pregnancies with 45,X/46,XX/
47,XXX karyotype resulted in miscarriage or malformed
fetus [10]. Similarly, Bryman et al. have reported that 45 %
of cases with mostly 45,X/46,XX mosaicism who con-
ceived with their own oocytes ended with miscarriage and
10 % of them with induced abortion [32]. Moreover, Kuo
et al. have reported miscarriage rate as 68.6 % in patients
with diminished ovarian reserve and 44.1 % in patients
without diminished ovarian reserve among cases who had
a history of prior recurrent spontaneous abortions with X
chromosome mosaicism [38]. Among our patients, 67.3 %
of the pregnancies were resulted in abortion or termin-
ation. However karyotyping was performed for nine cases
in our study group due to recurrent pregnancy loss. This
condition was a reason of how we detected a high abor-
tion rate and besides, this rate is quite higher than the
abortion rate of 10-15 % in the population [39].
Miscarriages that are frequently seen in TS cases are
explained by chromosomal abnormalities in fetus, auto-
immune disorders, ovarian and uterine factors [10, 11,
38, 40]. Aborted fetuses of TS women or their live born
children are more susceptible to trisomy 21 (4 % vs
0.4 %, respectively) and TS (15 % vs 0.5 %, respectively)
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nature was reported in mosaic TS cases and especially
cases with ring chromosome [10, 41]. Singh et al. re-
vealed in their study investigating 97 conceptions in 31
pregnant women with sex chromosome mosaicism that
75 % of the fetuses were abnormal and 50 % of these
pregnancies were resulted in spontaneous abortion and
25 % had genetic or congenital abnormalities [42]. Be-
sides, it was reported that abnormal karyotype ratio was
increased from 42.9 % up to 73.7 % in abortion samples
in the presence of diminished ovarian reserve [38]. Bir-
kebaek et al. detected chromosomal aberrations in 6 of
25 pregnancies who underwent prenatal or postnatal
cytogenetic analysis among TS cases with classical and
mosaic forms [4]. In our study fetal karyotype analysis
was not performed in all pregnancies terminated by
abortion, hence the exact abnormality rates cannot be
predicted however it seems likely to be higher. Cerebral
paresis, neuropsychological disorder, aortic coarctation,
cleft lip and palate and congenital tumor were detected
in 5 (7 %) of 68 children born to women with TS [32].
Even mosaic, preimplantation diagnosis, chorionic villus
sampling or amniocentesis should be recommended for
the patients undergoing infertility treatment if pregnancy
is planned with their own oocytes since biological
children of TS women are under risk for chromosomal
abnormalities; and their children should be investigated
for birth defects after delivery.
Uterine hypoplasia and related reduced uterine perfu-
sion secondary to significant changes in utero-ovarian vas-
cular anatomy, and subclinical uterine abnormalities in TS
cases have been implicated in the etiology of miscarriages
[33, 38, 43]. Although abortion rate is higher in pregnant
women conceived with their own oocytes, use of donor
oocytes does not reduce pregnancy loss rate in mosaic TS
cases who underwent IVF (45 % with their own oocytes vs
26-30 % with donor oocytes) [32, 44]. This condition can
be suggested as the evidence of the effect of diminished
endometrial receptivity as well as oocyte-associated factors
in TS cases. In our study group, uterus hypoplasia was
present in one case and surgery-corrected uterine abnor-
mality was present in three cases. It has been reported that
uterine size were often normal in cases with mosaic
karyotype and that they experience spontaneous puberty
[45, 46]. Khastgir et al. have reported bicornuat uterus in
four (13.8 %) of 29 TS cases, 10 of whom had mosaic
karyotypes and miscarriage rate associated with uterus
hypoplasia, bicornuat uterus and low fertilization rate was
50 % [34]. Kuo et al. have reported that they detected
uterine abnormality in 16.7 % of mosaic X-chromosome
aneuploidies with a history of recurrent spontaneous abor-
tions and 5.2 % in the control group [38]. In our study, we
found the ratio of Mullerian abnormality in all mosaic TS
cases as 13.6 % and all pregnancies had terminated withabortions before the surgical corrections of the malforma-
tions. However, after the surgical corrections, four preg-
nancies were achieved and three terminated with delivery.
These results suggest that the rate of uterine abnormalities
in TS cases is high and that they may benefit from the
surgery.
TS patients may experience complications during
pregnancy due to congenital malformations and endo-
crine diseases, and should be evaluated for the presence
of these pathologies before IVF or pregnancy [7]. Gesta-
tional diabetes mellitus was present in two (11.8 %) of
17 pregnancies that achieved live birth. These rates are
close to those reported by Bryman et al. who affirmed a
pregnancy induced hypertension and gestational diabetes
rate of 5 % in TS cases, similar to the rate in general
population [32, 47, 48]. In our study population, there
was one pregnancy with a history of SGA fetus delivery
(5.9 %) and none of the cases had preterm delivery. In
TS, preterm delivery rate was reported between
8–37.1 % and low birth weight was between 8.8-27.5 %
[49, 50]. Given that the chromosomal aberrations arise
possibly from the transmission of the imbalances in the
genetic arrangements in mother to the offsprings (10),
genetic counseling should be offered to all who con-
ceived with autologous oocytes (11). Preimplantation
genetic diagnosis (PGD) may improve the chance of
conceiving in patients with recurrent ART failure and
TS (12).
Limitations of our study include its retrospective de-
sign, presence of some data that are based on patients’
memory, absence of a control group and inability to per-
form a karyotype analysis in all newborns. In the context
of lack of a control group, we should emphasize that it
was not possible to constitute a control group since the
present was not a population-based study. In addition, it
is obvious that it is difficult to conduct such a study in
this issue in a prospective fashion. Besides, maternal age
significantly affects gains and losses in sex chromosomes
[51–53]. A significant correlation was reported between
maternal age and incidence of 45,X cell after 51 years
old, and incidence of 45,X cell was reported to be 3.2-
5.1 % among the women older than this age [52, 54]. Al-
though cases in our study were younger than 46 years
old, mosaicism ratio in some cases, whose pregnancy
age was young but diagnosis age was advanced, may not
reflect exact karyotype profile. Moreover, in the study by
Hanson et al. percentage of cases with mosaic karyotype
was found to be 45 % only with karyotyping but it
reached to 70 % when FISH was used [3]. Mosaicism
ratio was given by the assessment of 100 metaphase
plaques in all cases in our study, and it should be con-
sidered that FISH method was not used while evaluating
our results. Last, the results obtained in the present
study might have been affected by the non-mosaicism-
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included had more than one pregnancy as we stressed
that 16 cases experienced 52 pregnancies.
Conclusion
Only a small proportion of the mosaic TS patients con-
ceive in the first 2 years of marriage, hence any possible
interventions should be considered within this period
and at as much younger ages as possible. In TS patients
who conceived, only 5.7 % take home baby whereas
67.3 % abort. Age of menarche and age of marriage
appear not to have any impact on the chance of conceiv-
ing. Mosaicism ratio does not affect the time to the first
pregnancy. Patients should be informed about high abor-
tion rates after pregnancy.
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